<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-10-20T18:43:24.090Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-10-20T18:43:24.090Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-10-20T18:43:24.090Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-10-20T18:43:24.090Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-10-20T18:43:24.090Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/BMNR:1792521791526</loc>
    <lastmod>2026-10-20T18:43:11.526Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BMNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Why Is Bitmine Stock Surging on Tuesday?</image:title>
      <image:caption>Bitmine Immersion Technologies (NYSE: BMNR) stock surged 5.94% to $22.84 on Tuesday, driven by a broader rally in crypto-linked equities as Bitcoin rose 1% to $82,646.03 and Ethereum gained 1.82% to $2,446. The surge followed Bitmine&#39;s acquisition of 12,535 Ethereum tokens last week, with total crypto holdings reaching $15.1 billion as of October 18. The company aims to accumulate 5% of Ethereum&#39;s total supply, having purchased Ethereum weekly since June 2025.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SMR:1792521673548</loc>
    <lastmod>2026-10-20T18:41:13.548Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SMR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barclays Downgrades NuScale Power to Underweight, Lowers Price Target to $5</image:title>
      <image:caption>Barclays analyst Christine Cho has downgraded NuScale Power (NYSE: SMR) from Equal-Weight to Underweight. The price target for the stock has been reduced from $11 to $5.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SPY:1792521610458</loc>
    <lastmod>2026-10-20T18:40:10.458Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>President Trump And Vice President JD Vance Make An Announcement; President Trump Says We&amp;#39;ll Have More Growth This Year; Will Be Very Strong On Budget This Year</image:title>
      <image:caption>President Trump and Vice President JD Vance announced expectations for economic growth this year, with Trump emphasizing a strong budgetary approach. Specific financial figures or growth percentages were not provided in the announcement. The news may influence market sentiment, particularly regarding the SPY stock ticker.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VOD:1792521511979</loc>
    <lastmod>2026-10-20T18:38:31.979Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barclays Downgrades Vodafone Group to Underweight</image:title>
      <image:caption>Barclays analyst Maurice Patrick has downgraded Vodafone Group (NASDAQ: VOD) from Equal-Weight to Underweight. This change in rating reflects a more cautious outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BMNR:1792521432387</loc>
    <lastmod>2026-10-20T18:37:12.387Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BMNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Why Is Bitmine Stock Surging on Tuesday?</image:title>
      <image:caption>Bitmine Immersion Technologies (NYSE: BMNR) stock surged 5.94% to $22.84 on Tuesday, driven by a broader rally in crypto-linked equities as Bitcoin and Ethereum prices increased. The company&#39;s recent purchase of 12,535 Ethereum tokens has contributed to positive sentiment, with total crypto holdings reported at $15.1 billion as of October 18. Despite a 57.22% decline over the past year, Bitmine&#39;s stock shows signs of stabilization, trading above key moving averages.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EYPT:1792521228200</loc>
    <lastmod>2026-10-20T18:33:48.200Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EYPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Laidlaw &amp;amp; Co. Downgrades EyePoint to Hold</image:title>
      <image:caption>Laidlaw &amp; Co. analyst Yale Jen has downgraded EyePoint Pharmaceuticals (NASDAQ: EYPT) from a &#39;Buy&#39; rating to &#39;Hold&#39;. This change reflects a shift in the analyst&#39;s outlook on the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CBRE:1792520757568</loc>
    <lastmod>2026-10-20T18:25:57.568Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CBRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CBRE Group shares are trading higher after the company announced a definitive agreement to acquire Onnec Group Limited.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BBY:1792520710075</loc>
    <lastmod>2026-10-20T18:25:10.075Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Halifax--Nova-Scotia--Canada---June-2022.jpg?width=250&amp;height=187</image:loc>
      <image:title>Best Buy Bets Big on Gaming, Launches New Platform Ahead of Holiday Rush</image:title>
      <image:caption>Best Buy Co., Inc. (NYSE: BBY) launched a new digital gaming platform called Best Buy Gamers, in partnership with IGN, aimed at enhancing customer engagement in the gaming sector. Following this announcement, Best Buy&#39;s stock rose approximately 2%, with Evercore ISI raising its price target from $90 to $95. The platform, which includes personalized content and in-store experiences, is expected to capitalize on upcoming major video game releases. As of the latest update, Best Buy shares were trading at $93.18, nearing a 52-week high of $96.53.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CBRE:1792520643828</loc>
    <lastmod>2026-10-20T18:24:03.828Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CBRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CBRE Group shares are trading higher after the company announced a definitive agreement to acquire Onnec Group Limited.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AXNX:1792520601929</loc>
    <lastmod>2026-10-20T18:23:21.929Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AXNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Axonex AI Group shares are trading lower after the company announced a 2-for-5 reverse stock split, effective October 22.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NBP:1792520496241</loc>
    <lastmod>2026-10-20T18:21:36.241Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NovaBridge shares are trading higher after the company’s subsidiary Visara secured an exclusive option to acquire worldwide rights to YOLO Immune&amp;#39;s YOL104-2, an investigational treatment for ocular surface squamous neoplasia.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NBIX:1792520279314</loc>
    <lastmod>2026-10-20T18:17:59.314Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NBIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Neurocrine Biosciences shares are trading higher after the company announced the initiation of its Phase 2 clinical study of investigational compound NBI-1117567  in adults with mild to moderate Alzheimer&amp;#39;s disease.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MA:1792520109400</loc>
    <lastmod>2026-10-20T18:15:09.400Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Mahmutlar--Turkey---June-01--2019-Master.jpg?width=250&amp;height=187</image:loc>
      <image:title>Mastercard Taps Coinbase, Cloudflare as AI Agents Learn to Pay</image:title>
      <image:caption>Mastercard (NYSE: MA) has launched early access to its AI agent payment system, following successful pilots with Coinbase and Cloudflare. The system allows developers to test features like buyer- and seller-side APIs and integrates spending controls for payments made via cards, bank accounts, and stablecoins. Mastercard&#39;s stock rose nearly 1% to $621, approaching resistance levels between $624 and $625, supported by a recent upward trend.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SNY:1792520035237</loc>
    <lastmod>2026-10-20T18:13:55.237Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Sanofi shares are trading higher after the company and Teva reported Phase 2b data showing duvakitug maintained efficacy through 44 weeks in ulcerative colitis and Crohn&amp;#39;s disease. Separately, Sanofi announced an mRNA therapeutics collaboration with ScionxBio.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BRZE:1792520000846</loc>
    <lastmod>2026-10-20T18:13:20.846Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BRZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Downgrades Braze to Perform</image:title>
      <image:caption>Oppenheimer analyst Brian Schwartz has downgraded Braze (NASDAQ: BRZE) from an &#39;Outperform&#39; rating to &#39;Perform&#39;. This change in rating reflects a shift in the analyst&#39;s outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QGEN:1792519915634</loc>
    <lastmod>2026-10-20T18:11:55.634Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Qiagen shares are trading higher following a report suggesting that EQT AB is in advanced talks to acquire the company.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SNPS:1792519872939</loc>
    <lastmod>2026-10-20T18:11:12.939Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Overweight on Synopsys, Raises Price Target to $574</image:title>
      <image:caption>Morgan Stanley analyst Lee Simpson has maintained an Overweight rating on Synopsys (NASDAQ: SNPS) and raised the price target from $500 to $574. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ZION:1792519803969</loc>
    <lastmod>2026-10-20T18:10:03.969Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZION/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Underweight on Zions Bancorp, Lowers Price Target to $77</image:title>
      <image:caption>Morgan Stanley analyst Manan Gosalia has maintained an Underweight rating on Zions Bancorp (NASDAQ: ZION) and has reduced the price target from $78 to $77. This adjustment reflects the firm&#39;s cautious outlook on the bank&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BULL:1792519760576</loc>
    <lastmod>2026-10-20T18:09:20.576Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BULL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>U.S. House China Committee Rebuts Webull’s Claims, Raises Concerns Over Chinese Access To Investor Data And Regulatory Violations</image:title>
      <image:caption>The U.S. House China Committee has countered claims made by Webull regarding its operations, expressing concerns about potential access to investor data by Chinese entities and highlighting possible regulatory violations. The committee&#39;s statement raises significant questions about Webull&#39;s ties to China and the implications for U.S. investors. The stock ticker for Webull is BULL.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IRON:1792519718990</loc>
    <lastmod>2026-10-20T18:08:38.990Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $92</image:title>
      <image:caption>Morgan Stanley analyst Sean Laaman has maintained an Overweight rating on Disc Medicine (NASDAQ: IRON) and increased the price target from $90 to $92. This adjustment reflects the firm&#39;s positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HLT:1792519704702</loc>
    <lastmod>2026-10-20T18:08:24.702Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hilton shares are trading higher after the company announced plans to transfer its stock listing from the NYSE to Nasdaq while retaining its HLT ticker symbol.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CWST:1792519657365</loc>
    <lastmod>2026-10-20T18:07:37.365Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CWST/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Jana Partners Built Stake In Casella Waste Systems, Urges Management To Improve Margins And Returns On Capital&amp;#39; - Reuters</image:title>
      <image:caption>Activist investment firm Jana Partners has acquired a stake in Casella Waste Systems (CWST) and is urging the company to enhance its profit margins and returns on invested capital. Casella, which has a market value of approximately $5.6 billion, has seen its shares decline by about 11% this year and has remained relatively flat over the past five years, underperforming compared to its competitors. The waste management sector is currently attracting significant investment interest.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ABVX:1792519632451</loc>
    <lastmod>2026-10-20T18:07:12.451Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Abivax shares are trading higher after Guggenheim reiterated its Buy rating on the stock and maintained a $175 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/STX:1792519349373</loc>
    <lastmod>2026-10-20T18:02:29.373Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Overweight on Seagate Technology Hldgs, Raises Price Target to $1200</image:title>
      <image:caption>Morgan Stanley analyst Erik Woodring has maintained an Overweight rating on Seagate Technology Holdings (NASDAQ: STX) and raised the price target from $1187 to $1200. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1792519225162</loc>
    <lastmod>2026-10-20T18:00:25.162Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;OpenAI Acquires Biotech Startup As AI Race Moves Into Drug Development&amp;#39; - Axios Exclusive</image:title>
      <image:caption>OpenAI has acquired a biotech startup as part of its strategy to expand into drug development, reflecting the growing intersection of artificial intelligence and biotechnology. This move comes amid increasing competition in the AI sector, particularly in healthcare applications. The acquisition is expected to enhance OpenAI&#39;s capabilities in developing AI-driven solutions for drug discovery and development.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EPRT:1792519050492</loc>
    <lastmod>2026-10-20T17:57:30.492Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EPRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Deutsche Bank Downgrades Essential Properties to Hold, Lowers Price Target to $28</image:title>
      <image:caption>Deutsche Bank analyst Omotayo Okusanya has downgraded Essential Properties (NYSE: EPRT) from a Buy rating to Hold. The price target for the stock has also been reduced from $38 to $28.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HR:1792518947720</loc>
    <lastmod>2026-10-20T17:55:47.720Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Deutsche Bank Upgrades Healthcare Realty Trust to Buy, Raises Price Target to $23</image:title>
      <image:caption>Deutsche Bank analyst Omotayo Okusanya has upgraded Healthcare Realty Trust (NYSE: HR) from Hold to Buy. The price target for the stock has been raised from $18 to $23.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KR:1792518876629</loc>
    <lastmod>2026-10-20T17:54:36.629Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Kroger to Invest $5 Billion on Improving Value, Lowering Prices&amp;#39; - Bloomberg News</image:title>
      <image:caption>Kroger has announced a $5 billion investment aimed at enhancing value and reducing prices for consumers. This strategic move is part of the company&#39;s broader effort to improve its competitive position in the grocery market. The investment is expected to impact Kroger&#39;s pricing strategy and overall market presence significantly.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMGN:1792518861747</loc>
    <lastmod>2026-10-20T17:54:21.747Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amgen shares are trading higher after the company and AstraZeneca reported that TEZSPIRE improved histologic remission and dysphagia in a Phase 3 trial for eosinophilic esophagitis.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CLYM:1792518858141</loc>
    <lastmod>2026-10-20T17:54:18.141Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLYM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Deutsche Bank Initiates Coverage On Climb Bio with Buy Rating, Announces Price Target of $28</image:title>
      <image:caption>Deutsche Bank analyst David Hoang has initiated coverage on Climb Bio (NASDAQ: CLYM) with a Buy rating. The firm has set a price target of $28 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AZN:1792518792416</loc>
    <lastmod>2026-10-20T17:53:12.416Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AstraZeneca shares are trading higher after the company and Amgen reported that TEZSPIRE demonstrated meaning improvements in histologic remission and dysphagia in a Phase 3 CROSSING trial for eosinophilic esophagitis.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VICR:1792518640055</loc>
    <lastmod>2026-10-20T17:50:40.055Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VICR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Needham Reiterates Buy on Vicor, Maintains $350 Price Target</image:title>
      <image:caption>Needham analyst N. Quinn Bolton has reiterated a Buy rating on Vicor (NASDAQ: VICR) and maintained a price target of $350 for the stock. This endorsement suggests continued confidence in Vicor&#39;s performance and potential for growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MMM:1792518535914</loc>
    <lastmod>2026-10-20T17:48:55.914Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/3M-MMM.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is 3M Stock Soaring Tuesday?</image:title>
      <image:caption>3M Co. (NYSE: MMM) stock rose 6.00% to $171.73 after the company raised its 2026 earnings guidance to $9.10-$9.15 per share, exceeding analysts&#39; estimates. The third-quarter results showed a 4.2% revenue increase to $6.6 billion, supported by strong industrial demand and new product launches, although it slightly missed the consensus estimate. The Safety and Industrial segment reported 7% organic sales growth, while overall sales from new products surged 34% year-to-date. 3M also expects to surpass its 2027 profitability targets, maintaining an adjusted operating margin forecast of approximately 24.6%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1792518449738</loc>
    <lastmod>2026-10-20T17:47:29.738Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BMO Capital Maintains Outperform on Microsoft, Raises Price Target to $600</image:title>
      <image:caption>BMO Capital analyst Keith Bachman has maintained an &#39;Outperform&#39; rating on Microsoft (NASDAQ: MSFT) and raised the price target from $515 to $600. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/USO:1792518411470</loc>
    <lastmod>2026-10-20T17:46:51.470Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Reported Earlier: The Hormuz Letter Posted On X &amp;#34;Iran announces an oil tanker has caught fire in the US-backed southern Omani corridor of the Strait of Hormuz today, after hitting a naval mine.&amp;#34;</image:title>
      <image:caption>Iran has announced that an oil tanker caught fire in the US-backed southern Omani corridor of the Strait of Hormuz after hitting a naval mine. This incident could have implications for oil supply routes and may affect market dynamics, particularly for oil-related stocks such as USO.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GOOGL:1792518384882</loc>
    <lastmod>2026-10-20T17:46:24.882Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BMO Capital Maintains Outperform on Alphabet, Raises Price Target to $480</image:title>
      <image:caption>BMO Capital analyst Brian Pitz has maintained an &#39;Outperform&#39; rating on Alphabet (NASDAQ: GOOGL) and raised the price target from $465 to $480. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMGN:1792518271362</loc>
    <lastmod>2026-10-20T17:44:31.362Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amgen shares are trading higher after the company and AstraZeneca reported Phase 3 data showing TEZSPIRE met co-primary and key secondary endpoints in eosinophilic esophagitis.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ABBV:1792518103088</loc>
    <lastmod>2026-10-20T17:41:43.088Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AbbVie shares are trading higher after Health Canada approved SKYRIZI for pediatric plaque psoriasis patients and the company announced a multiyear partnership with the McLaren Mastercard Formula 1 Team.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TRI:1792517743295</loc>
    <lastmod>2026-10-20T17:35:43.295Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TRI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Thomson Reuters shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a $130 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GOOG:1792517715618</loc>
    <lastmod>2026-10-20T17:35:15.618Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Mountain-View--Ca--Usa---May-1--2022-Goo.jpg?width=250&amp;height=187</image:loc>
      <image:title>Alphabet Earnings Ahead: Cloud Growth, Gemini, TPU Sales Could Drive Upside</image:title>
      <image:caption>Alphabet Inc (NASDAQ: GOOG) is set to report its third-quarter earnings on October 28, with expected revenue of $111.4 billion and GAAP earnings of $3.07 per share, surpassing analyst expectations. The company&#39;s Cloud segment is projected to grow by 93%, exceeding the consensus estimate of 89%. However, Alphabet faces headwinds including legal charges and costs associated with SpaceX. Currently, Alphabet shares are trading at $337.63, down 0.74%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NFLX:1792517379762</loc>
    <lastmod>2026-10-20T17:29:39.762Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Netflix Ads Suite Has Better Buying, Better Planning, Better Results; Plans To Expand Ads To 15 New Countries</image:title>
      <image:caption>Netflix announced enhancements to its advertising suite, which include improved buying, planning, and results for advertisers. The company plans to expand its advertising services to 15 new countries, aiming to increase its market presence and revenue from ad sales. This strategic move reflects Netflix&#39;s ongoing efforts to diversify its revenue streams beyond subscription services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HNGE:1792517349783</loc>
    <lastmod>2026-10-20T17:29:09.783Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HNGE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Watching Hinge Health; Shares See Volume To The Upside, Hearing Investor Business Daily SwingTrader Buys Stock</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LION:1792517300124</loc>
    <lastmod>2026-10-20T17:28:20.124Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LION/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lionsgate Studios shares are trading higher following a report suggesting that Legendary Entertainment has revived talks to acquire the company and submitted a takeover offer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TRI:1792517287949</loc>
    <lastmod>2026-10-20T17:28:07.949Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TRI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jefferies Initiates Coverage On Thomson Reuters with Buy Rating, Announces Price Target of $130</image:title>
      <image:caption>Jefferies analyst Surinder Thind has initiated coverage on Thomson Reuters (NASDAQ: TRI) with a Buy rating. The firm has set a price target of $130 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AZN:1792517218608</loc>
    <lastmod>2026-10-20T17:26:58.608Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research</image:title>
      <image:caption>Oracle Corp. (NYSE: ORCL) has entered a nonbinding agreement with AstraZeneca Plc (NYSE: AZN) to leverage artificial intelligence and real-world data for enhancing clinical-trial recruitment and connecting research with patient care. The collaboration aims to identify eligible patients more quickly and improve evidence generation, focusing on areas such as oncology and rare diseases. During premarket trading, AstraZeneca shares rose by 1.82% to $166.93, while Oracle shares fell by 1.61% to $127.51.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GPC:1792517214460</loc>
    <lastmod>2026-10-20T17:26:54.460Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Konskie--Poland---January-25--2024-Genui.jpg?width=250&amp;height=187</image:loc>
      <image:title>Genuine Parts Slashes 2026 Profit Outlook, Stock Falls</image:title>
      <image:caption>Genuine Parts Co. (NYSE: GPC) reported mixed third-quarter results, with adjusted earnings of $2.07 per share surpassing analyst estimates of $2.05, while revenue of $6.521 billion fell short of expectations of $6.523 billion. The company lowered its 2026 GAAP earnings forecast to $5.60-$5.85 per share, down from $5.90-$6.40, and narrowed its adjusted earnings forecast to $7.50-$7.75 per share. Following the announcement, GPC&#39;s stock dropped 6.28% to $122.00 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GPC:1792517200517</loc>
    <lastmod>2026-10-20T17:26:40.517Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Genuine Parts Slashes 2026 Profit Outlook, Stock Falls</image:title>
      <image:caption>Genuine Parts Co. reported third-quarter adjusted earnings of $2.07 per share, exceeding analyst expectations of $2.05, but revenue of $6.521 billion fell short of the $6.523 billion forecast. The company lowered its 2026 GAAP earnings outlook to $5.60-$5.85 per share, down from $5.90-$6.40, and below the analyst estimate of $6.78. Despite these adjustments, Genuine Parts maintained its full-year sales growth outlook of 3% to 5.5% and reaffirmed its operating cash flow forecast of $1 billion to $1.2 billion. Following the news, GPC stock fell 6.28% to $122.00 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AZN:1792517197448</loc>
    <lastmod>2026-10-20T17:26:37.448Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Konskie--Poland---November-13--2024-Orac.jpg?width=250&amp;height=187</image:loc>
      <image:title>Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research</image:title>
      <image:caption>Oracle Corp. has entered a nonbinding agreement with AstraZeneca Plc to leverage artificial intelligence and real-world data for improving clinical-trial recruitment and connecting research findings with everyday care. The collaboration aims to expedite patient eligibility identification, expand trial access, and enhance evidence generation, focusing on areas such as oncology and cardiovascular diseases. In premarket trading, AstraZeneca shares rose by 1.82% to $166.93, while Oracle shares fell by 1.61% to $127.51.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AAL:1792517131183</loc>
    <lastmod>2026-10-20T17:25:31.183Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/American-Airlines.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is American Airlines Stock Surging Tuesday?</image:title>
      <image:caption>American Airlines Group Inc. (NASDAQ: AAL) saw its stock surge 4.44% to $12.20 on Tuesday, driven by a 1% drop in crude oil prices, which fell below $97 per barrel, easing fuel cost pressures for airlines. The positive sentiment was further bolstered by GE Aerospace&#39;s strong third-quarter results, reporting adjusted earnings of $2.25 per share on revenue of $13.285 billion, exceeding Wall Street estimates. American Airlines is set to report its third-quarter results on October 22, with expectations of a loss of 36 cents per share and revenue projected to rise to $16.21 billion from $13.69 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NOW:1792516853541</loc>
    <lastmod>2026-10-20T17:20:53.541Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Shares of software companies are trading higher as the sector rebounds from recent weakness. Also, recent economic data raised expectations that the Fed will skip interest rate hikes this month.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
</urlset>